CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences

With news of the US Supreme Court’s recent Oil States decision and the UK’s ratification of the Unified Patent Court Agreement capturing the headlines in recent days, patent professionals might be forgiven for allowing a crucial CRISPR-Cas9 dispute…

Unlock unlimited access to all IAM content